S. Sundberg - Concepedia

Author

S. Sundberg

Orion Corporation (Finland)

Also Known As

S SUNDBERG, S Sundberg, S. SUNDBERG, S. Sundberg, Sari A Sundberg

Publications

706

Citations

H-Index

Concepts

All Affiliations

Orion Corporation (Finland)Helsinki University Hospital University of Helsinki Orion Corporation (United Kingdom)University of Turku

About

S. Sundberg is an author at Orion Corporation (Finland) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	377
2	Health Sciences	4	4	98
3	Anesthesia	4	4	170
4	Public Health	1	1	39
5	Social Sciences	1	1	21

S. Sundberg

Publications

633

Citations

H-Index

Page 1

	Year	Citations
Dental care and treatments provided under general anaesthesia in the Helsinki Public Dental Service Nora Savanheimo, S. Sundberg, Jorma I. Virtanen, BMC Oral Health	2012	87
Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction. Jyrki Lilleberg, S. Sundberg, Markku S. Nieminen PubMed HypertensionHeart FailureCardiovascular PharmacologyPharmacotherapyDiastolic Function	1995	71
Effect of Hydroxyethyl Starch and Dextran on Plasma Volume and Blood Hemostasis and Coagulation Kari Korttila, Pentti Gröhn, A. Gordin, The Journal of Clinical Pharmacology	1984	69
Haemodynamic dose-efficacy of levosimendan in healthy volunteers Jyrki Lilleberg, M NIEMINEN, S. Sundberg, European Journal of Clinical Pharmacology MedicineHealthy VolunteersClinical PharmacologyPharmacotherapyAnesthesia	1994	58
Dose-Range Study of a New Calcium Sensitizer, Levosimendan, in Patients with Left Ventricular Dysfunction Jyrki Lilleberg, S. Sundberg, Markku S. Nieminen Journal of Cardiovascular Pharmacology Cardiac MuscleHeart FailureCardiovascular PharmacologyPharmacotherapyDiastolic Function	1995	56
Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals. S. Sundberg, Saila Antila, Harry Scheinin, PubMed	1998	43
Impairment of captopril bioavailability by concomitant food and antacid intake. R Mäntylä, Pekka T. Männistö, Arja Vuorela, PubMed NutritionDietary ExposurePeak Captopril ConcentrationsExperimental NutritionDietary Intake	1984	39
The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise S. Sundberg, Mika Scheinin, Ari Illi, British Journal of Clinical Pharmacology PharmacotherapyExperimental PharmacologyClinical PhysiologyKinesiologyExercise	1993	32
COMT inhibition by high-dose entacapone does not affect hemodynamics but changes catecholamine metabolism in healthy volunteers at rest and during exercise. Ari Illi, S. Sundberg, Markku Koulu, PubMed Physiological ResearchClinical PhysiologyExerciseHealthy VolunteersExercise Physiology	1994	29
Haemodynamic interactions between the novel calcium sensitiser levosimendan and isosorbide-5-mononitrate in healthy subjects L. Lehtonen, S. Sundberg European Journal of Clinical Pharmacology Healthy SubjectsHaemodynamic InteractionsMedicinePhysiologyAnesthetic Mechanism	2000	26

Page 1